{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:24:40Z","timestamp":1793413480407,"version":"4.5.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T00:00:00Z","timestamp":1748217600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007219","name":"Shanghai Municipal Natural Science Foundation","doi-asserted-by":"publisher","award":["24ZR1450000"],"award-info":[{"award-number":["24ZR1450000"]}],"id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007219","name":"Shanghai Municipal Natural Science Foundation","doi-asserted-by":"publisher","award":["23ZR1441200"],"award-info":[{"award-number":["23ZR1441200"]}],"id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82472014"],"award-info":[{"award-number":["82472014"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81901162"],"award-info":[{"award-number":["81901162"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.neurot.2025.e00618","type":"journal-article","created":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T21:55:08Z","timestamp":1749160508000},"page":"e00618","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Restoring glucose metabolism in Alzheimer's disease by targeting integrated stress response"],"prefix":"10.1016","volume":"22","author":[{"given":"Hui","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenrui","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongfu","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyuan","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suyun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenglai","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yafu","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10284","key":"10.1016\/j.neurot.2025.e00618_bib1","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","article-title":"Alzheimer's disease","volume":"397","author":"Scheltens","year":"2021","journal-title":"The Lancet"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00618_bib2","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1152\/physrev.00015.2020","article-title":"The complexity of Alzheimer's disease: an evolving puzzle","volume":"101","author":"Ferrari","year":"2021","journal-title":"Physiol Rev"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00618_bib3","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1146\/annurev-neuro-070815-014015","article-title":"Alzheimer's disease mechanisms and emerging roads to novel therapeutics","volume":"39","author":"Sala Frigerio","year":"2016","journal-title":"Annu Rev Neurosci"},{"issue":"9","key":"10.1016\/j.neurot.2025.e00618_bib4","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa1202753","article-title":"Clinical and biomarker changes in dominantly inherited Alzheimer's disease","volume":"367","author":"Bateman","year":"2012","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00618_bib5","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jalz.2017.09.011","article-title":"Evidence for brain glucose dysregulation in Alzheimer's disease","volume":"14","author":"An","year":"2018","journal-title":"Alzheimer's Dementia"},{"issue":"12","key":"10.1016\/j.neurot.2025.e00618_bib6","doi-asserted-by":"crossref","first-page":"3742","DOI":"10.1093\/brain\/awab222","article-title":"Riluzole, a glutamate modulator, slows cerebral glucose metabolism decline in patients with Alzheimer's disease","volume":"144","author":"Matthews","year":"2021","journal-title":"Brain"},{"issue":"6711","key":"10.1016\/j.neurot.2025.e00618_bib7","article-title":"Restoring hippocampal glucose metabolism rescues cognition across Alzheimer's disease pathologies","volume":"385","author":"Minhas","year":"2024","journal-title":"Sci Technol Humanit"},{"issue":"16","key":"10.1016\/j.neurot.2025.e00618_bib8","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.3390\/cells12162019","article-title":"Hypometabolism, alzheimer's disease, and possible therapeutic targets: an overview","volume":"12","author":"Raut","year":"2023","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00618_bib9","article-title":"18 F-FDG PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI)","author":"Vacante","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00618_bib10","doi-asserted-by":"crossref","first-page":"W76","DOI":"10.2214\/AJR.13.12363","article-title":"Brain FDG PET and the diagnosis of dementia","volume":"204","author":"Shivamurthy","year":"2015","journal-title":"Am J Roentgenol"},{"issue":"10","key":"10.1016\/j.neurot.2025.e00618_bib11","doi-asserted-by":"crossref","first-page":"7340","DOI":"10.1002\/alz.14165","article-title":"The ADNI PET core at 20","volume":"20","author":"Jagust","year":"2024","journal-title":"Alzheimer's Dement"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00618_bib12","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S1474-4422(18)30029-2","article-title":"Cognitive and neuroimaging features and brain \u03b2-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study","volume":"17","author":"Dubois","year":"2018","journal-title":"Lancet Neurol"},{"issue":"12","key":"10.1016\/j.neurot.2025.e00618_bib13","doi-asserted-by":"crossref","first-page":"8979","DOI":"10.1002\/alz.14258","article-title":"Retrosplenial hypometabolism precedes the conversion from mild cognitive impairment to Alzheimer\u2019s disease","volume":"20","author":"Terstege","year":"2024","journal-title":"Alzheimer\u2019s Dement"},{"issue":"17","key":"10.1016\/j.neurot.2025.e00618_bib14","doi-asserted-by":"crossref","first-page":"9540","DOI":"10.3390\/ijms23179540","article-title":"Dysfunctional glucose metabolism in Alzheimer's disease onset and potential pharmacological interventions","volume":"23","author":"Kumar","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.neurot.2025.e00618_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.626636","article-title":"A systematic review of glucose transport alterations in Alzheimer's disease","volume":"15","author":"Kyrtata","year":"2021","journal-title":"Front Neurosci"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00618_bib16","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.3233\/JAD-160841","article-title":"Glucose transporters in brain: in health and in Alzheimer's disease","volume":"55","author":"Szablewski","year":"2016","journal-title":"J Alzheim Dis"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00618_bib17","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/s41583-019-0132-6","article-title":"Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease","volume":"20","author":"Butterfield","year":"2019","journal-title":"Nat Rev Neurosci"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00618_bib18","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nn.3966","article-title":"GLUT1 reductions exacerbate Alzheimer's disease vasculo-neuronal dysfunction and degeneration","volume":"18","author":"Winkler","year":"2015","journal-title":"Nat Neurosci"},{"issue":"7","key":"10.1016\/j.neurot.2025.e00618_bib19","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1093\/brain\/awp099","article-title":"Reduced O-GlcNAcylation links lower brain glucose metabolism and tau pathology in Alzheimer's disease","volume":"132","author":"Liu","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.neurot.2025.e00618_bib20","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.pneurobio.2013.06.004","article-title":"Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies","volume":"108","author":"Chen","year":"2013","journal-title":"Prog Neurobiol"},{"issue":"109","key":"10.1016\/j.neurot.2025.e00618_bib21","doi-asserted-by":"crossref","DOI":"10.3791\/53308","article-title":"Intracerebroventricular injection of amyloid-\u03b2 peptides in normal mice to acutely induce Alzheimer-like cognitive deficits","author":"Kim","year":"2016","journal-title":"J Vis Exp"},{"key":"10.1016\/j.neurot.2025.e00618_bib22","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.nbd.2019.03.008","article-title":"Regional hypometabolism in the 3xTg mouse model of Alzheimer's disease","volume":"127","author":"Adlimoghaddam","year":"2019","journal-title":"Neurobiol Dis"},{"issue":"10","key":"10.1016\/j.neurot.2025.e00618_bib23","doi-asserted-by":"crossref","first-page":"944","DOI":"10.3390\/pharmaceutics12100944","article-title":"Cognitive impairment in the 3xTg-AD mouse model of Alzheimer's disease is affected by A\u03b2-immunotherapy and cognitive stimulation","volume":"12","author":"Roda","year":"2020","journal-title":"Pharmaceutics"},{"issue":"24","key":"10.1016\/j.neurot.2025.e00618_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242417423","article-title":"Integrated stress response (ISR) pathway: unraveling its role in cellular senescence","volume":"24","author":"Kalinin","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"6489","key":"10.1016\/j.neurot.2025.e00618_bib25","article-title":"The integrated stress response: from mechanism to disease","volume":"368","author":"Costa-Mattioli","year":"2020","journal-title":"Sci Technol Humanit"},{"key":"10.1016\/j.neurot.2025.e00618_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108122","article-title":"Physiology and pharmacology of amyloid precursor protein","volume":"235","author":"Cho","year":"2022","journal-title":"Pharmacol Therapeut"},{"issue":"667","key":"10.1016\/j.neurot.2025.e00618_bib27","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abn9380","article-title":"Synaptogenic effect of APP-Swedish mutation in familial Alzheimer's disease","volume":"14","author":"Zhou","year":"2022","journal-title":"Sci Transl Med"},{"issue":"31","key":"10.1016\/j.neurot.2025.e00618_bib28","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2407472121","article-title":"The ISR downstream target ATF4 represses long-term memory in a cell type\u2013specific manner","volume":"121","author":"Mahmood","year":"2024","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.neurot.2025.e00618_bib29","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.cortex.2024.07.004","article-title":"Cerebral glucose metabolism in Alzheimer\u2019s disease","volume":"179","author":"Salmon","year":"2024","journal-title":"Cortex"},{"key":"10.1016\/j.neurot.2025.e00618_bib30","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s40336-013-0026-y","article-title":"Glucose metabolism in normal aging and Alzheimer's disease: methodological and physiological considerations for PET studies","volume":"1","author":"Mosconi","year":"2013","journal-title":"Clinical and translational imaging"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00618_bib31","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.3390\/ijms22042110","article-title":"Imaging techniques in Alzheimer's disease: a review of applications in early diagnosis and longitudinal monitoring","volume":"22","author":"van Oostveen","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00618_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112335","article-title":"Neurons require glucose uptake and glycolysis in vivo","volume":"42","author":"Li","year":"2023","journal-title":"Cell Rep"},{"key":"10.1016\/j.neurot.2025.e00618_bib33","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.lfs.2017.10.033","article-title":"Reprogramming energetic metabolism in Alzheimer's disease","volume":"193","author":"Vall\u00e9e","year":"2018","journal-title":"Life Sci"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00618_bib34","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s40478-021-01208-4","article-title":"Altered ribosomal function and protein synthesis caused by tau","volume":"9","author":"Evans","year":"2021","journal-title":"Acta Neuropathologica Communications"},{"key":"10.1016\/j.neurot.2025.e00618_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.conb.2024.102886","article-title":"The integrated stress response in brain diseases: a double-edged sword for proteostasis and synapses","volume":"87","author":"Lockshin","year":"2024","journal-title":"Curr Opin Neurobiol"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00618_bib36","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s41398-022-01862-9","article-title":"Inhibition of the ISR abrogates mGluR5-dependent long-term depression and spatial memory deficits in a rat model of Alzheimer's disease","volume":"12","author":"Hu","year":"2022","journal-title":"Transl Psychiatry"},{"issue":"8","key":"10.1016\/j.neurot.2025.e00618_bib37","doi-asserted-by":"crossref","first-page":"4351","DOI":"10.3390\/ijms23084351","article-title":"Glucose metabolism, neural cell senescence and Alzheimer's disease","volume":"23","author":"Wang","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00618_bib38","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/febs.15073","article-title":"Structural insights into ISRIB, a memory-enhancing inhibitor of the integrated stress response","volume":"287","author":"Anand","year":"2020","journal-title":"FEBS J"},{"issue":"31","key":"10.1016\/j.neurot.2025.e00618_bib39","doi-asserted-by":"crossref","first-page":"E6420","DOI":"10.1073\/pnas.1707661114","article-title":"Inhibition of the integrated stress response reverses cognitive deficits after traumatic brain injury","volume":"114","author":"Chou","year":"2017","journal-title":"Proc Natl Acad Sci"},{"issue":"6467","key":"10.1016\/j.neurot.2025.e00618_bib40","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1126\/science.aaw5185","article-title":"Activation of the ISR mediates the behavioral and neurophysiological abnormalities in Down syndrome","volume":"366","author":"Zhu","year":"2019","journal-title":"Science."},{"issue":"3","key":"10.1016\/j.neurot.2025.e00618_bib41","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/bph.16260","article-title":"Pharmacological inhibition of the integrated stress response accelerates disease progression in an amyotrophic lateral sclerosis mouse model","volume":"181","author":"Marlin","year":"2024","journal-title":"Br J Pharmacol"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00618_bib42","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.3390\/ijms23063146","article-title":"Sovateltide mediated endothelin B receptors agonism and curbing neurological disorders","volume":"23","author":"Ranjan","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00618_bib43","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early Alzheimer's disease","volume":"388","author":"Van Dyck","year":"2023","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.neurot.2025.e00618_bib44","doi-asserted-by":"crossref","first-page":"4757","DOI":"10.1016\/j.cell.2023.09.023","article-title":"Accelerating Alzheimer's therapeutic development: the past and future of clinical trials","volume":"186","author":"Boxer","year":"2023","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00618_bib45","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/s41582-022-00768-w","article-title":"Lecanemab trial in AD brings hope but requires greater clarity","volume":"19","author":"Thambisetty","year":"2023","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.neurot.2025.e00618_bib46","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3389\/fmed.2019.00071","article-title":"18F-FDG-PET in mouse models of Alzheimer's disease","volume":"6","author":"Bouter","year":"2019","journal-title":"Front Med"},{"issue":"s1","key":"10.1016\/j.neurot.2025.e00618_bib47","doi-asserted-by":"crossref","first-page":"S579","DOI":"10.3233\/JAD-240206","article-title":"PET\/CT\/MRI in clinical trials of alzheimer's disease","volume":"101","author":"H\u00f8ilund-Carlsen","year":"2024","journal-title":"J Alzheim Dis"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00618_bib48","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.3233\/JAD-190220","article-title":"18F-FDG is a superior indicator of cognitive performance compared to 18F-florbetapir in Alzheimer's disease and mild cognitive impairment evaluation: a global quantitative analysis","volume":"70","author":"Khosravi","year":"2019","journal-title":"J Alzheim Dis"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747925000960?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747925000960?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T13:08:42Z","timestamp":1758114522000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747925000960"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":48,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S1878747925000960"],"URL":"https:\/\/doi.org\/10.1016\/j.neurot.2025.e00618","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Restoring glucose metabolism in Alzheimer's disease by targeting integrated stress response","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurot.2025.e00618","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of American Society for Experimental NeuroTherapeutics.","name":"copyright","label":"Copyright"}],"article-number":"e00618"}}